Flock Feed Overlaps Watchlist Portfolio Insider Calendar Search Account

Feed
Overlap
Watch
Folio
Insider
Cal
Search
Me

Flock — Smart-money disclosures, made readable

Viking Therapeutics Inc

VKTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

BlackRock
13F filer
$319.4M
6,026,131 sh
as-of 30 Jun 2024Stale
Two Sigma Investments
13F filer
$144.2M
4,432,142 sh
as-of 31 Mar 2026Quarterly
Duquesne Family Office
13F filer
$14.6M
549,295 sh
as-of 30 Jun 2025Stale
Soros Fund Management
13F filer
$3.2M
90,000 sh
as-of 31 Dec 2025Stale
Bridgewater Associates
13F filer
$2.3M
71,229 sh
as-of 31 Mar 2026Quarterly

Ownership

Ownership data not yet available for this security.

Disclosure timeline

DISCLOSEDQuarterly
Two Sigma Investments
Viking Therapeutics Inc · NASDAQ
4,432,142 sh · $144.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
Viking Therapeutics Inc · NASDAQ
71,229 sh · $2.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Soros Fund Management
Viking Therapeutics Inc · NASDAQ
90,000 sh · $3.2M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Viking Therapeutics Inc · NASDAQ
549,295 sh · $14.6M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Viking Therapeutics Inc · NASDAQ
6,026,131 sh · $319.4M
Filed 30 Jun 2024SEC 13Fview source

Announcements

No announcements on record for this security.

VKTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Latest filing31 Mar 2026Stale

5 disclosed holders · 5 disclosures · 0 announcements

Ownership

Ownership data not yet available for this security.

Announcements

No announcements on record for this security.